Xometry (NASDAQ:XMTR – Get Free Report)‘s stock had its “market outperform” rating restated by investment analysts at Citizens Jmp in a research note issued to investors on Monday, Benzinga reports. They currently have a $120.00 price objective on the stock. Citizens Jmp’s price objective would suggest a potential upside of 14.14% from the stock’s current price.
XMTR has been the topic of several other reports. Cantor Fitzgerald boosted their price target on Xometry from $85.00 to $110.00 and gave the company an “overweight” rating in a research note on Wednesday, August 5th. BNP Paribas Exane began coverage on Xometry in a report on Friday, September 18th. They set an “outperform” rating and a $120.00 price objective on the stock. UBS Group boosted their price objective on Xometry from $88.00 to $95.00 and gave the company a “neutral” rating in a research report on Wednesday, August 5th. Weiss Ratings restated a “sell (d-)” rating on shares of Xometry in a research note on Wednesday, August 26th. Finally, Royal Bank Of Canada raised their target price on Xometry from $85.00 to $100.00 and gave the stock a “sector perform” rating in a research report on Wednesday, August 5th. Eight investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $113.18.
View Our Latest Stock Report on Xometry
Xometry Stock Up 5.6%
Xometry (NASDAQ:XMTR – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.16 EPS for the quarter, beating the consensus estimate of $0.15 by $0.01. The firm had revenue of $229.28 million during the quarter, compared to analysts’ expectations of $215.22 million. Xometry had a negative net margin of 3.82% and a negative return on equity of 2.88%. The business’s quarterly revenue was up 41.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.09 EPS. As a group, sell-side analysts anticipate that Xometry will post -0.01 earnings per share for the current year.
Insiders Place Their Bets
In related news, Director Randolph Altschuler sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $90.82, for a total transaction of $908,200.00. Following the completion of the transaction, the director owned 551,270 shares in the company, valued at $50,066,341.40. This trade represents a 1.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Fabio Rosati sold 8,100 shares of the business’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $91.45, for a total value of $740,745.00. Following the completion of the sale, the director directly owned 93,567 shares in the company, valued at approximately $8,556,702.15. This represents a 7.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 57,053 shares of company stock worth $5,244,213 in the last 90 days. 9.10% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Xometry
Hedge funds have recently made changes to their positions in the company. Quantinno Capital Management LP boosted its stake in Xometry by 759.5% in the first quarter. Quantinno Capital Management LP now owns 32,694 shares of the company’s stock worth $1,335,000 after purchasing an additional 28,890 shares in the last quarter. Sylebra Capital LLC increased its stake in shares of Xometry by 31.3% in the first quarter. Sylebra Capital LLC now owns 535,624 shares of the company’s stock valued at $21,875,000 after buying an additional 127,637 shares in the last quarter. Empowered Funds LLC acquired a new stake in shares of Xometry in the first quarter valued at $1,150,000. Polen Capital Management LLC raised its holdings in shares of Xometry by 169.3% in the fourth quarter. Polen Capital Management LLC now owns 22,321 shares of the company’s stock valued at $1,327,000 after buying an additional 14,031 shares during the last quarter. Finally, Penn Capital Management Company LLC bought a new position in shares of Xometry in the fourth quarter valued at about $1,899,000. Institutional investors and hedge funds own 97.31% of the company’s stock.
Xometry Company Profile
Xometry, Inc operates a digital marketplace that connects businesses with manufacturing suppliers. Its platform uses software and data-driven tools to help customers obtain quotes, place orders and manage production for custom parts and products.
The company supports a range of manufacturing processes, including CNC machining, 3D printing, sheet-metal fabrication, injection molding and urethane casting. Its services are used for prototyping and production across industries such as aerospace, automotive, industrial equipment, consumer products and healthcare.
Founded in 2013, Xometry has expanded its marketplace and related technology offerings through organic development and acquisitions, including the 2021 acquisition of Thomas, a digital industrial sourcing and marketing business.
Further Reading
- Five stocks we like better than Xometry
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
- AMD Chips Away at NVIDIA’s AI Throne
- Is the Fed Playing Chess With Rates—Or Just Behind the Curve Again?
Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.
